TREK-1 activity can also be changed during pathology since the activation of TREK-1 by Polyunsaturated fatty acids like arachidonic acid might occur in pathophysiological situations like ischemia when ATP cause the release of this fatty acid (Aimond et al., 2000). The gene discussed is KCNK2; the disease is ischemia.